Diabetes biomarker


A gene, molecule, or innate characteristic that aids in diagnosing disease is known as a molecular biomarker. HbA1c is regarded as a biomarker for diabetes that can be used to detect retinopathy, vascular disease, and nephropathy risk factors. They serve as prophylactic actions while the condition is subclinical. A quicker and more thorough understanding of the pathological process of diabetes can be achieved with the right use of the biomarker in the development of anti-diabetic medications.



 


    Related Conference of Diabetes biomarker

    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 18-19, 2025

    13th World Congress and Expo on Green Energy

    Valencia, Spain
    August 21-22, 2025

    20th World Convention on Waste Recycling and Reuse

    Paris, France
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France
    September 22-23, 2025

    17th World Congress and Expo on Recycling

    Dubai, UAE
    October 27-28, 2025

    19th Global Summit and Expo on Biomass and Bioenergy

    London, UK
    November 13-14, 2025

    14th World Conference on Earth Science & Geology

    Paris, France
    November 13-14, 2025

    19th World Congress on Biofuels and Bioenergy

    Paris, France
    November 20-21, 2025

    14th International Conference on Climate Change & Environmental Science

    London, UK

    Diabetes biomarker Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in